Media Centre
Latest press releases
-
Trastuzumab deruxtecan recommended for approval in the EU by CHMP for HER2-positive metastatic breast cancer
-
Trixeo Aerosphere approved in the EU for maintenance treatment of COPD
-
AstraZeneca to acquire Alexion, accelerating the Company's strategic and financial development
-
Enhertu continues to demonstrate durable responses with new data from DESTINY-Breast01 in HER2-positive metastatic breast cancer
-
AZD1222 Oxford Phase III trials interim analysis results published in The Lancet
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 203 749 5916
Rebecca Einhorn
Director Global Media Relations (Oncology)
+1 301 398 1802
Kim Blomley
Director Global Media Relations (Oncology)
+44 7385 367659
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 203 749 5906
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 122 334 4690
Jennifer Hursit
Manager Global Media Relations
+44 203 749 5762
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
